Soft Tissue Sarcoma
Also known as: Sarcoma of Soft Tissue / Soft-tissue Sarcomas / Soft-Tissue Sarcoma / Sarcoma, Soft-tissue / Soft Tissue Sarcoma (STS) / Soft Tissue Sarcomas / Sarcoma,Soft Tissue / Sarcoma, Soft Tissue / Non-rhabdomyosarcoma soft-tissue sarcoma / Sarcoma of soft tissue (disorder) / Sarcoma, no ICD-O subtype (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|---|---|
DB01248 | Docetaxel | A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. |
DB00445 | Epirubicin | An anthracycline topoisomerase II inhibitor used as an adjuvant to treating axillary node metastases in patients who have undergone surgical resection of primary breast cancer. |
DB01181 | Ifosfamide | An alkylating and immunosuppressive agent used in chemotherapy for the treatment of cancers, including testicular cancer, ovarian cancer, cervical cancer, osteocarcinoma, bladder cancer, small cell lung cancer, and non-Hodgkin's lymphoma. |
DB00563 | Methotrexate | An antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis. |
DB06043 | Olaratumab | A platelet-derived growth factor receptor alpha blocking antibody used with doxorubicin to treat patients with certain types of soft tissue sarcoma (STS). |
DB00853 | Temozolomide | An alkylating agent used to treat glioblastoma multiforme and refractory anaplastic astrocytoma. |
DB00361 | Vinorelbine | A vinca alkaloid used in the treatment of metastatic non-small cell lung carcinoma (NSLC) and in conjunction with other drugs in locally advanced NSCLC. |